Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1014-1018

  Lauw, Fanny N ^a   Ten Hove, Tessa ^a   Dekkers, Pascale E P ^a   De Jonge, Evert ^a   Van Deventer, Sander J H ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY CD3; STAPHYLOCOCCUS ENTEROTOXIN B;

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLU LIKE SYNDROME; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEPSIS;

ADULT; CYTOKINES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; LIPOPOLYSACCHARIDES; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; TH1 CELLS; TH2 CELLS;

EID: 0033963967     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1014-1018.2000     Document Type: Article

References (34)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
2. Agarwal, S. K., and G. D. Marshall, Jr. 1998. Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction. J. Interferon Cytokine Res. 18:1059-1068.
3. Barber, A. E., S. M. Coyle, M. A. Marano, E. Fischer, S. E. Calvano, Y. Fong, L. L. Moldawer, and S. F. Lowry. 1993. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J. Immunol. 150:1999-2006.
4. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
5. Bohuslav, J., V. V. Kravchenko, G. C. Parry, J. H. Erlich, S. Gerondakis, N. Mackman, and R. J. Ulevitch. 1998. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J. Clin. Investig. 102: 1645-1652.
6. Brandtzaeg, P., L. Osnes, R. Ovstebo, G. Britt Joo, A. B. Westvik, and P. Kierulf. 1996. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J. Exp. Med. 184:51-60.
7. Castro, A., V. Bemer, A. Nobrega, A. Coutinho, and P. Truffa-Bachi. 1998. Administration to mice of endotoxin from gram-negative bacteria leads to activation and apoplosis of T lymphocytes. Eur. J. Immunol. 28:488-495.
8. Decker, D., M. Schöndorf, F. Bidlingmaier, A. Hirner, and A. A. von Ruecker. 1996. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 119:316-325.
9. Docke, W. D., F. Randow, U. Syrbe, D. Krausch, K. Asadullah, P. Reinke, H. D. Volk, and W. Kox. 1997. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 3:678-681.
10. Ertel, W., J. P. Kremer, J. Kenney, U. Steckholzer, D. Jarrar, O. Trentz, and F. W. Schildberg. 1995. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347.
11. Gillessen, S., D. Carvajal, P. Ling, F. J. Podlaski, D. L. Stremlo, P. C. Familletti, C. Gubler, D. H. Presky, A. S. Stern, and M. K. Gately. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:200-206.
12. Granowitz, E. V., R. Porat, J. W. Mier, S. F. Orencole, G. Kaplanski, E. A. Lynch, K. Ye, E. Vannier, S. M. Wolff, and C. A. Dinarello. 1993. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 151:1637-1645.
13. Heinzel, F. P., A. M. Hujer, F. N. Ahmed, and R. M. Rerko. 1997. In vivo production and function of IL-12 p40 homodimers. J. Immunol. 158:4381-4388.
14. Hensler, T., H. Hecker, K. Heeg, C. D. Heidecke, H. Bartels, W. Barthlen, H. Wagner, J. R. Siewert, and B. Holzmann. 1997. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect. Immun. 65:2283-2291.
15. Keuter, M., E. Dharmana, M. H. Gasem, J. van der Ven-Jongekrijg, R. Djokomoeljanto, W. M. Dolmans, P. Demacker, R. Sauerwein, H. Gallati, and J. W. van der Meer. 1994. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J. Infect. Dis. 169:1306-1311.
16. Lemaire, L. C. J. M., T. van der Poll, J. J. B. van Lanschot, E. Endert, W. A. Buurman, S. J. H. van Deventer, and D. J. Gouma. 1998. Minimally invasive surgery induces endotoxin-tolerance in the absence of detectable endotoxemia. J. Clin. Immunol. 18:414-420.
17. Marie, C., J. Muret, C. Fitting, M. R. Losser, D. Payen, and J. M. Cavaillon. 1998. Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome. Blood 91:3439-3446.
18. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
19. Mattner, F., L. Ozmen, F. J. Podlaski, V. L. Wilkinson, D. H. Presky, M. K. Gately, and G. Alber. 1997. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock. Infect. Immun. 65:4734-4737.
20. McCall, C. E., L. M. Grosso-Wilmoth, K. LaRue, R. N. Guzman, and S. L. Cousart. 1993. Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans with the sepsis syndrome. J. Clin. Investig. 91:853-861.
21. Micallef, M. J., T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, M. Namba, T. Tanimoto, K. Torigoe, M. Fujii, M. Ikeda, S. Fukuda, and M. Kurimoto. 1996. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 26:1647-1651.
22. Mossman, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138-146.
23. Munoz, C., J. Carlet, C. Fitting, B. Misset, J. P. Bleriot, and J. P. Bleriot, and J. M. Cavaillon. 1991. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Investig. 88:1747-1754.
24. Mureille, E., and O. Leo. 1998. Revisiting the Th1/Th2 paradigm. Scand. J. Immunol. 47:1-9.
25. Novick, D., S. H. Kim, G. Fantuzzi, L. L. Reznikov, C. A. Dinarello, and M. Rubinstein. 1999. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10:127-136.
26. O'Sullivan, S. T., J. A. Lederer, A. F. Horgan, D. H. Chin, J. A. Mannick, and M. L. Rodrick. 1995. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222:482-492.
27. Petrovsky, N., and L. C. Harrison. 1997. Diurnal rhythmicity of human cytokine production. A dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J. Immunol. 158:5163-5168.
28. Prins, J. M., E. J. Kuijper, M. L. Mevissen, P. Speelman, and S. J. H. van Deventer. 1995. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect. Immun. 63:2236-2242.
29. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. O'Garra. 1997. IGIF does not drive ThI development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFκ B. Immunity 7:571-581.
30. van der Poll, T., A. E. Barber, S. M. Coyle, and S. F. Lowry. 1996. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - a clinical research center study. J. Clin. Endocrinol. Metab. 81:3604-3606.
31. van der Poll, T., S. M. Coyle, K. Barbosa, C. C. Braxton, and S. F. Lowry. 1996. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J. Clin. Investig. 97:713-719.
32. van der Poll, T., S. M. Coyle, L. L. Moldawer, and S. F. Lowry. 1996. Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxin. J. Infect. Dis. 174:1356-1360.
33. van der Poll, T., and S. J. H. van Deventer. 1999. Endotoxemia in healthy subjects as a human model of inflammation, p. 335-357. In J. Cohen and J. Marshall (ed.), The immune response in the critically ill. Springer-Verlag, New York, N.Y.
34. van Deuren, M., J. van der Ven-Jongekrijg, P. N. Demacker, A. K. Bartelink, R. van Dalen, R. W. Sauerwein, H. Gallati, J. L. Vannice, and J. W. van der Meer. 1994. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J. Infect. Dis. 169: 157-161.